Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.35 |
| ▸ | XBP1 | P17861 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | IDH1 | O75874 | 1/20 | 0.34 |
| ▸ | CACNA1A | O00555 | 1/20 | 0.33 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.33 |
| ▸ | CACNB1 | Q02641 | 1/20 | 0.33 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.33 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.33 |
| ▸ | F2R | P25116 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23544539 | 1.00 | GAA (0.35) | GAAXBP1ATMNPSR1L3MBTL1 | |
| SCHEMBL17791350 | 0.95 | GAA (0.34) | GAAXBP1ATMNPSR1L3MBTL1 | |
| SCHEMBL16803235 | 0.95 | GAA (0.34) | GAAXBP1ATMNPSR1L3MBTL1 | |
| SCHEMBL13677623 | 0.94 | GAA (0.32) | GAAXBP1ATMNPSR1L3MBTL1 | |
| SCHEMBL12345496 | 0.94 | GAA (0.32) | GAAXBP1ATMNPSR1L3MBTL1 | |
| SCHEMBL13992714 | 0.94 | GAA (0.35) | GAAPKMHTTIDH1CACNA1A | |
| SCHEMBL9971643 | 0.93 | KCNH2 (0.32) | GAAXBP1ATMNPSR1L3MBTL1 | |
| SCHEMBL2813206 | 0.92 | GAA (0.31) | GAAXBP1ATMNPSR1L3MBTL1 | |
| SCHEMBL805448 | 0.92 | NR5A2 (0.32) | GAAXBP1ATMNPSR1L3MBTL1 | |
| SCHEMBL13647666 | 0.92 | CYP2D6 (0.46) | GAAXBP1ATMNPSR1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12043782-B2 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2024-07-23 | — | — | US | disclosed |
| US-12043782-B2 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2024-07-23 | — | — | US | disclosed |
| US-12043781-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2024-07-23 | — | — | US | disclosed |
| US-12043781-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2024-07-23 | — | — | US | disclosed |
| EP-4400561-A1 | LIQUID-CRYSTAL MEDIUM | Merck Patent GmbH (DE) | 2024-07-17 | — | — | EP | disclosed |
| WO-2024132893-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024126567-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2024-06-20 | — | — | WO | disclosed |
| EP-3924447-B1 | POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | MERCK PATENT GMBH (DE) | 2024-01-24 | — | — | EP | disclosed |
| EP-4306614-A1 | LIQUID-CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2024-01-17 | — | — | EP | disclosed |
| US-11873438-B2 | Liquid-crystal medium | MERCK PATENT GMBH (DE) | 2024-01-16 | — | — | US | disclosed |
| US-7175891-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2007-02-13 | — | — | US | disclosed |
| US-7175891-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2007-02-13 | — | — | US | disclosed |
| EP-1431369-B1 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2007-01-31 | — | — | EP | disclosed |
| WO-2007009636-A1 | S-INDACENE AND INDENO[5,6-D][1,3]DIOXOL-DERIVATIVES AND USE THEREOF AS COMPONENTS OF LIQUID-CRYSTAL MIXTURES | MERCK PATENT GMBH (DE) | 2007-01-25 | — | — | WO | disclosed |
| EP-1746079-A2 | Fluorinated biphenyl compounds for use in liquid crystal compositions | Merck Patent GmbH (DE) | 2007-01-24 | — | — | EP | disclosed |
| US-20070001149-A1 | Liquid-crystal medium containing monofluoroterphenyl compounds | MERCK PATENT GMBH (DE) | 2007-01-04 | — | — | US | disclosed |
| EP-1310474-B1 | Fluorinated biphenyl compounds and their use in liquid crystal compositions | MERCK PATENT GMBH (DE) | 2007-01-03 | — | — | EP | disclosed |
| EP-1365001-B1 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2007-01-03 | — | — | EP | disclosed |
| US-20040164279-A1 | Solid melt blended phosphite composites | WELLS FARGO BANK, NATIONAL ASSOCIATION | 2004-08-26 | — | — | US | disclosed |
| US-5733973-A | High solids binder compositions containing OH-functional polyacrylate graft copolymers | BAYER AKTIENGESELLSCHAFT (DE) | 1998-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040164279-A1 | Solid melt blended phosphite composites | PHOSPHO1, MTAP, INPPL1 | GAA 2474/4885XBP1 3043/4885ATM 625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.